AI generated summary of Pubmed citation/abstract with PMID 38091833

https://pubmed.ncbi.nlm.nih.gov/38091833

Neoadjuvant chemotherapy for gastric cancer alters the tumor immune microenvironment to have an anti-tumorigenic effect, which is associated with improved patient prognosis.